The T cell specific adapter protein (TSAd) 
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. Both environmental and genetic factors contribute to the disease. 1 Several genomewide screenings have suggested that over 20 genetic regions could encompass susceptibility genes, [2] [3] [4] [5] [6] but the only genetic factor which firmly has been shown to contribute to MS is HLA. 7 Recently, we cloned the cDNA 8 as well as the SH2D2A gene 9 encoding a T cell specific adapter protein (TSAd), which appears to be involved in inhibiting early T cell signaling events. 10 The SH2D2A gene is located close to the CD1 region on chromosome 1q21. 9 This region confers susceptibility to develop chronic allergic encephalomyelitis 11 and viral induced encephalomyelitis 12 as well as chronic collagen induced arthritis 13 in the mouse (as reviewed in Holmdahl SH2D2A gene. 9 Such length polymorphisms in the regulatory regions of genes have been implied in the genetic susceptibility to diseases. [15] [16] [17] We therefore studied whether the SH2D2A gene contributes to the genetic susceptibility to MS by analyzing unrelated Norwegian MS patients and controls, as well as Scandinavian families with at least two affected siblings. Our results indicate that short alleles of the SH2D2A gene contribute to the genetic susceptibility to develop MS. Interestingly, we also found that the MS associated short alleles confer lower expression of TSAd in activated T cells than the long alleles not associated with MS.
Results
MS is associated with short alleles of the GA repeat in the SH2D2A promoter Length polymorphisms in promoter regions have been shown to modulate the expression of the accompanying gene, 15, 16, 18 as well as the genetic susceptibility to various diseases. [15] [16] [17] The SH2D2A gene is located in a genetic region, which has been implicated in the genetic susceptibility to EAE in the mouse. We therefore postulated that the GA repeat polymorphism in the SH2D2A promoter region, 9 which has a characteristic bimodal frequency distribution (Figure 1 ), could confer susceptibility to develop MS. We first examined the distribution of the SH2D2A alleles among 313 Norwegian MS patients and 277 Norwegian healthy controls. The frequency of short (GA [13] [14] [15] [16] ) repeats was increased among MS patients (0.332 vs 0.249; OR 1.5; Pc = 0.03; Table 1 ; Figure 1) . Accordingly, the frequency of short GA [13] [14] [15] [16] homozygotes was increased among the MS patients (12% vs 6%; OR 2.0; P = 0.025; Table 1 ), while the frequency of the long GA [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] homozygotes was decreased (45% vs 56%; OR 0.6; P = 0.01; Table 1 ). The frequency of GA [13] [14] [15] [16] homozygotes was higher among HLA-DR2
+ patients than HLA-DR2 − patients (14% (25/179) vs 9% (10/116)). This difference however did not reach statistical significance. We then performed a transmission disequilibrium test of the SH2D2A alleles in 146 Scandinavian MS sib pair families with two affected sibs. The overall transmission of GA repeat alleles among the patients was skewed ( 2 16df 39.07; P = 0.001). The short GA 16 allele made the largest contribution to the overall 2 statistic ( Table 2 ). The transmission distortion was independent of the sex of the parent (data not shown). When the analysis was repeated with alleles grouped into short or long alleles, the short GA [13] [14] [15] [16] alleles were significantly more often transmitted than the long alleles ( 2 1df 4.77; P = 0.03). In order to assess whether the observed transmission distortion was mainly due to the Norwegian contribution to the Scandinavian sibling material, we randomly selec- Table 1 Distribution of short (GA [13] [14] [15] [16] ) and long (GA [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] 27 The 2 values are therefore not directly comparable to traditional TdT test. 28 When performing TdT test with the 59 families with one or two parents present, the GA 16 allele was transmitted 35 times, and not transmitted 15 times ( 2 = 8.0, P Ͻ 0.005), whereas the GA 20 was transmitted four times, and not transmitted 12 times
ted one patient from each of the 92 Swedish and Danish sibling pairs. The frequency of GA [13] [14] [15] [16] alleles among these unrelated patients was 0.385 compared to 0.302 among 158 unrelated Swedish and Danish controls (OR 1.4, P = 0.06). Correspondingly, 16% of the patients were homozygous for GA [13] [14] [15] [16] alleles compared to 7% among the controls (OR 2.6, P = 0.03). Thus, although statistically borderline, the strength of association of MS to GA [13] [14] [15] [16] alleles as assessed by OR among the Swedish and Danish MS patients were comparable to that observed in the Norwegian case-control material.
Linkage analysis of the SH2D2A chromosomal region 1q21
To investigate whether the observed association to SH2D2A alleles was due to linkage disequilibrium with another disease contributing gene in the vicinity of SH2D2A, we performed a multi-point linkage analysis of a region extending approximately 15 cM to each side of the SH2D2A locus among the Scandinavian sib pair families using four additional markers. Only a very weak positive LOD score was observed for the SH2D2A locus itself. None of the four other markers in the SH2D2A region on 1q21 tested in the families showed evidence of transmission distortion in MS patients (figure not shown).
The GA repeat length in the SH2D2A promoter influences the expression of the TSAd protein In order to investigate whether the SH2D2A promoter genotype influences the relative increase in TSAd expression after T-cell activation, resting CD4 + T cells enriched by negative selection from nine individuals with known SH2D2A genotypes were activated by cross-linking of CD3 and CD28, and the cells were harvested at different time points. The increase in TSAd expression was measured relative to the constant level of ZAP 70 expression using Western blot and digital registration of chemiluminesence signals (Figure 2a ). Individuals carrying at least one copy of a long SH2D2A promoter allele displayed a higher induction of TSAd expression at all time points after activation compared with individuals being homozygous for short SH2D2A alleles (Figure 2b ). Forty-eight hours after activation where the TSAd expression reaches its maximum, 10 an eight-fold increase in TSAd expression was observed in cells having at least one long SH2D2A allele compared to a three and a halffold increase in cells being homozygous for short SH2D2A alleles (Figure 2b ).
Single nucleotide polymorphisms (SNP) are located in the promoter region of the SH2D2A gene In order to evaluate whether the SH2D2A promoter contains other polymorphisms than the GA repeat which could influence disease susceptibility or expression of the gene, we sequenced 1 kb of the promoter region upstream of the first coding ATG in exon 1 of a total of 10 individuals. Six healthy blood donors of which four had also been included in the ex vivo TSAd expression assay and four MS patients carrying either short GA alleles (GA 13 or GA 16 ) or long GA alleles (GA 22 or GA 23 ). Sequence data were aligned and compared to the published sequence (GenBank: AF106072). Two single nucleotide polymorphism were identified upstream of the GA repeat ( Table 3) . As can be seen, the −628A and −446T alleles were only found on genotypes containing the GA 16 allele.
Discussion
This study demonstrates that a polymorphism in the promoter region of the SH2D2A gene encoding the T cell specific adapter protein TSAd may contribute to the genetic susceptibility to develop MS. The observation that the MS associated short alleles of the SH2D2A gene were less expressed than long alleles not associated with MS, suggests that this polymorphism may directly influence the susceptibility to develop MS. Moreover, the finding that the alleles increased or decreased are clustered among short and long alleles, respectively, further strengthens the assumption that these alleles themselves contribute directly to the genetic susceptibility. The association of the SH2D2A promoter GA repeat polymorphism to MS could be due to a gene in linkage disequilibrium with the SH2D2A gene, because there are several immunologically important genes in this region, such as the CD1 gene cluster and the CD3Z gene. We did not find evidence of linkage or association of MS to other genes in the vicinity of the SH2D2A gene. The lack of linkage to markers in the 1q21 region among MS families is in accordance with previous genome screens. [2] [3] [4] [5] [6] Lack of linkage in the presence of association is to be expected for genes of small effect or genes that are neither necessary nor sufficient for the development of disease. 19, 20 Thus, the finding that MS was not linked to markers in the vicinity of the SH2D2A gene lends support to the notion that it could be the SH2D2A gene itself and not flanking genes, which confer the disease susceptibility.
Genes and Immunity
The TSAd protein encoded by the SH2D2A gene 
a The evaluated region extended from position +6 to −1000 of the SH2D2A promoter.
b Sample nos. 1, 2, 8 and 10 were MS patients, while nos. 4, 5, 7 and 9 were healthy persons. Sample nos. 3, 6 and 11 were promoter fragments from two different healthy controls with different GA alleles subcloned into a luciferase reporter plasmid. The published sequence from cosmid clone AH118a10 was included for comparison. inhibits early T cell activation. 10 Within 2 h after triggering of the T cell receptor (TCR), the expression of TSAd increased in T cells, and the increased expression is maintained for at least 24 h. 8 Thus, TSAd may be important in downregulating activated T cells. We observed that the genotype of the SH2D2A promoter influences TSAd expression in CD4 + T cells after activation through the TCR/CD3 complex. Since lower expression of the inhibitory TSAd protein in the T cell after activation could increase the propensity of T cells to stay activated, this could be a mechanism whereby the associated SH2D2A alleles increase the susceptibility to develop MS. The association of the GA repeat to MS and to the level of SH2D2A gene expression could be due to other polymorphisms of the SH2D2A gene in linkage disequilibrium with the GA repeat. Sequencing of 1 kb of the SH2D2A promoter upstream of the first coding ATG from a total of 10 individuals, revealed two variant nucleotides which were only present on chromosomes carrying the GA 16 allele. Whether these single nucleotide polymorphisms influence the expression of the SH2D2A gene is unknown. Polymorphisms located at other positions in the gene than in the promoter region, for instance in the 3Ј untranslated region, could also influence gene expression level. Further studies to elucidate the role of polymorphisms on the regulation of the SH2D2A gene are clearly needed, and such studies are presently under way in our laboratory.
There is generally a strong selection against polymorphisms in coding regions of genes. 21 This may be because changes in the amino acid sequence could yield a dysfunctional protein. Variation in the expression level of a gene will probably not be hazardous to the same extent since this will only affect the fine-tuning of the function.
In an evolutionary perspective, this type of variation could also be more convenient, since it will allow for individual variation in the response to environmental challenges without the risk of destroying the function of the gene. Thus, if polymorphisms modifying the expression are selected, it is to be expected that the same polymorphisms sometimes may have adverse affects, such as increasing the susceptibility to autoimmune diseases like MS.
Subjects and methods

Unrelated patients and controls
The 313 Norwegian unrelated MS patients and the 277 healthy controls were living in the Oslo area. All patients fulfilled the Poser criteria for clinically definite or laboratory supported definite MS. 22 A total of 295 of the MS patients have previously been genomically typed for HLA class II alleles. 23 The Scandinavian control material consisted of 78 Danish and 80 Swedish healthy controls.
Scandinavian sib pair families
A total of 150 Caucasian sib pair families (31 with both parents, 30 with only one parent and 89 with no parents) were included. All patients had clinically definite MS according to the Poser criteria. Sib pairs from Denmark (58 families) and Norway (40 families) were collected from the whole country; sib pairs from Finland (14 families) were collected from the Turku area, whereas sib pairs from Sweden (38 families) were recruited from the Lund and Stockholm areas. Where one or both parents were missing, blood from the available parent and from unaffected siblings was sampled. Genotypic data was obtained from 146 of these families, yielding the equivalent of 162 nuclear families, out of which 146 included two or more affected offspring. Genotypes from a total of 675 individuals were included in the present study. The protocol was approved by the regional Ethics Committee, and informed consent was obtained from each patient and relatives of the patient.
Typing of microsatelite markers in the 1q21 region
Peripheral venous blood was sampled, and DNA was isolated from leukocytes by standard procedures. 24 In vitro amplification by polymerase chain reaction (PCR) was PCR products containing the SH2D2A GA repeat were obtained from genomic DNA using the following primers: primer 1 5Ј TCCCCATTCCCACTGCTC 3Ј; primer 2 5ЈCCTGACCTTCATCCCTCC 3Ј. One of the primers was fluorescence-labelled. Four additional highly polymorphic microsatellite markers (D1S252, D1S2140, D1S1653 and D1S196) were selected for linkage analysis of the chromosome 1q21 region. The markers cover 30 cM (155-186 cM). Sequences of fluorescent labelled primers and PCR amplification protocols of the microsatellite loci markers were obtained from the Genome Database (http://www.gdb.org/). PCR products were analyzed on an ABI automatic sequencing machine (ABI Prism  XL 377; Perkin-Elmer, Foster City, CA, USA). Data was collected and analyzed with the Gene Scan  2.10 program, and was visualized with the Genotyper  2.0 program.
Ex vivo assay of TSAd expression
Resting CD4 + enriched T cells from nine healthy persons, carrying either two long alleles (either of GA 22 or GA 23 ), two short alleles (either of GA 13 or GA 16 ) or one long allele and one short allele were assessed for expression of TSAd after activation through the TCR/CD3 complex. Peripheral blood mononuclear cells (PBMC) were prepared freshly by Ficoll gradient centrifugation. Monocytes, B cells, activated T cells and other MHC II bearing cells were depleted using Dynabeads  HLA class II (Dynal, Oslo, Norway) specific for the MHC II ␤ chain (bead:cell-ratio was 6:1). CD8
+ T cells were subsequently depleted using Dynabeads  HLA class I (Dynal) specific for CD8 (bead:cell-ratio was 9:2).
The quality of the CD4 + cell enrichment was monitored by flow cytometry on a FACSort flow cytometer (Becton Dickinson, San Jose, CA, USA) by staining PBMC and CD4
+ enriched cells with monoclonal antibodies specific for CD4 (clone SK3; Becton Dickinson), CD8 (clone SK1; Becton Dickinson), CD16 (clone 3G8; PharMingen, San Diego, CA, USA) or TCR␥␦ (clone 11F2; Becton Dickinson). The CD4 + enriched cells were stimulated by cross-linking CD3 (clone OKT3, mouse IgG2a, ATCC, Manassas, VA, USA) and CD28 (clone CD28.2, Mouse IgG 1 , , PharMingen) as previously described. 10 At certain time points after stimulation, cells were harvested and cell pellets were stored at −70°C for subsequent assessment of TSAd and ZAP-70 expression by Western blot as previously described. 10 All samples from one individual were analyzed on the same gel. A standardized amount of lysate from a Jurkat Tag cell line (3A3) stably transfected with TSAd cDNA 10 Sequencing of the SH2D2A promoter The promoter region of four healthy controls and four MS patients homozygous for short (either of GA 13 or GA 16 ) or long (either of GA 22 or GA 23 ) alleles were directly sequenced from genomic DNA. Sequencing templates were PCR products covering the previous published SH2D2A promoter sequence 9 were amplified with suitable primers (GenBank: AF106072). Sequencing was performed using the ABI Prism 
Statistical analysis
The frequencies of short and long SH2D2A alleles in unrelated patients and controls were compared by the 2 test, using the Public Domain Software for Epidemiology and Disease Surveillance EPI Info Version 5.01b (Center for Disease Control, Epidemiology Program Office, Atlanta, GA, USA). The level of significance was set to 0.05. Odds ratio (OR) was calculated according to Wolf with Haldane's continuity correction. 26 The P values were corrected where appropriate with the number of alleles observed minus 1 (ie 15) which corresponds to the number of possible divisions of the alleles into two groups based on their length. Transmission disequilibrium analysis in the Scandinavian sib pair material was done using the Transmit program (version 2.5), which performs transmission-disequilibrium test for uncertainhaplotype transmission. 27 This method allows the inclusion of families with one or both parents missing, such that all available information from the material can be extracted. We also analyzed the 59 families with one or two parents with the original TdT test (http:// spielman07.med.upenn.edu/TDT.htm). 28 Linkage analysis was done using an affected sib pair method. Under the null hypothesis of no linkage, 25% of sib pairs are expected to share two alleles, 50% one allele and 25% no alleles. If evidence for linkage is found, a skew in favor of sib pairs sharing alleles will occur. In families where parental genotyping data are missing the probability of identity by decent (IBD) sharing can be estimated from the underlying population allele frequencies, which in our analysis were calculated from the family data using the SPLINK program (version 1.04). 29 The information extracted from the set of families can be increased by performing a multipoint analysis which allows by descent sharing of alleles from homozygous parents to be estimated by combining knowledge of the genetic map with the sharing observed at flanking markers. In our analysis we used the non-parametric multipoint sib pair program MAPMAKER/SIBS (version 1.09). 30 
